Skip to main content
. 2012 Dec 18;168(1):189–199. doi: 10.1111/j.1476-5381.2012.02123.x

Figure 6.

Figure 6

Activation of Bcl-2 by rHuEPO and non-erythropoietic derivatives. Representative immunoblot of Bcl-2 from three independent experiments, indicating that Bcl-2 was markedly lower in unstimulated P19 cells. rHuEPO and GEPO treatments markedly increased Bcl-2 levels. In addition, Bcl-2 activation by rHuEPO and GEPO was inhibited by a JAK-2 inhibitor. In contrast, activation of Bcl-2 by CEPO was less impressive and independent of JAK-2 inhibition.